Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.

Comparison of two drug regimens upon clinical outcome among renal transplant recipients with positive flow cytometric crossmatches.

Kimball P, Wagner B, King A, Fisher RA, Dawson S, Cotterell A, Posner M.

Clin Transplant. 2002 Aug;16(4):290-4.

PMID:
12099986
[PubMed - indexed for MEDLINE]
2.

Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.

Kerman RH, Susskind B, Buyse I, Pryzbylowski P, Ruth J, Warnell S, Gruber SA, Katz S, Van Buren CT, Kahan BD.

Transplantation. 1999 Dec 27;68(12):1855-8.

PMID:
10628764
[PubMed - indexed for MEDLINE]
3.

Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.

Gruessner RW.

Clin Transplant. 1997 Aug;11(4):299-312.

PMID:
9267719
[PubMed - indexed for MEDLINE]
4.

Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.

Ciancio G, Burke GW, Suzart K, Roth D, Kupin W, Rosen A, Olson L, Esquenazi V, Miller J.

Transplantation. 2002 Apr 15;73(7):1100-6.

PMID:
11965039
[PubMed - indexed for MEDLINE]
5.

Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.

Lenaers JI, Christiaans MH, Voorter CE, van Hooff HP, van den Berg-Loonen EM.

Transplantation. 2006 Nov 15;82(9):1142-7.

PMID:
17102764
[PubMed - indexed for MEDLINE]
6.

The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients.

Kotb M, Russell WC, Hathaway DK, Gaber LW, Gaber AO.

Clin Transplant. 1999 Feb;13(1 Pt 2):83-9.

PMID:
10081642
[PubMed - indexed for MEDLINE]
7.

Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.

Mehra MR, Uber PA, Scott RL, Park MH.

Transplantation. 2002 Dec 15;74(11):1568-73.

PMID:
12490790
[PubMed - indexed for MEDLINE]
8.

The flow cytometric crossmatch and early renal transplant loss.

Mahoney RJ, Ault KA, Given SR, Adams RJ, Breggia AC, Paris PA, Palomaki GE, Hitchcox SA, White BW, Himmelfarb J, et al.

Transplantation. 1990 Mar;49(3):527-35.

PMID:
2138366
[PubMed - indexed for MEDLINE]
9.

Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.

O'Rourke RW, Osorio RW, Freise CE, Lou CD, Garovoy MR, Bacchetti P, Ascher NL, Melzer JS, Roberts JP, Stock PG.

Clin Transplant. 2000 Apr;14(2):167-73.

PMID:
10770424
[PubMed - indexed for MEDLINE]
10.

New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.

Ulsh PJ, Yang HC, Holman MJ, Ahsan N.

J Transpl Coord. 1999 Jun;9(2):114-8.

PMID:
10703393
[PubMed - indexed for MEDLINE]
11.

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.

Ahsan N, Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.

Transplantation. 2001 Jul 27;72(2):245-50.

PMID:
11477347
[PubMed - indexed for MEDLINE]
12.

Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.

Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS.

Transplantation. 1998 Jan 27;65(2):180-7.

PMID:
9458011
[PubMed - indexed for MEDLINE]
13.

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

Pelletier RP, Akin B, Henry ML, Bumgardner GL, Elkhammas EA, Rajab A, Ferguson RM.

Clin Transplant. 2003 Jun;17(3):200-5.

PMID:
12780668
[PubMed - indexed for MEDLINE]
14.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

PMID:
15899149
[PubMed - indexed for MEDLINE]
Free Article
15.

Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.

Favi E, Spagnoletti G, Salerno MP, Pedroso JA, Romagnoli J, Citterio F.

Clin Transplant. 2013 Jul-Aug;27(4):E359-67. doi: 10.1111/ctr.12141. Epub 2013 May 26.

PMID:
23710603
[PubMed - indexed for MEDLINE]
16.

Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols.

Chkhotua AB, Klein T, Shabtai E, Yussim A, Bar-Nathan N, Shaharabani E, Lustig S, Mor E.

Urology. 2003 Dec;62(6):1002-6.

PMID:
14665344
[PubMed - indexed for MEDLINE]
17.

Clinical aspects of sensitization.

Katznelson S, Bhaduri S, Cecka JM.

Clin Transpl. 1997:285-96.

PMID:
9919412
[PubMed - indexed for MEDLINE]
18.

Is positive flow cytometric cross-match a risk factor for early cadaveric kidney graft dysfunction?

Piatosa B, Rubik J, Grenda R.

Transplant Proc. 2006 Jan-Feb;38(1):53-5.

PMID:
16504662
[PubMed - indexed for MEDLINE]
19.

Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.

Neu AM, Ho PL, Fine RN, Furth SL, Fivush BA.

Pediatr Transplant. 2003 Jun;7(3):217-22.

PMID:
12756047
[PubMed - indexed for MEDLINE]
20.

Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.

Ilham MA, Winkler S, Coates E, Rizzello A, Rees TJ, Asderakis A.

Transplant Proc. 2008 Jul-Aug;40(6):1839-43. doi: 10.1016/j.transproceed.2008.05.009.

PMID:
18675065
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk